-
Consumers will have a new generic alternative to the widely used — and pricey — device to counter life-threatening allergic reactions.
-
Mylan is recalling some EpiPens distributed between December 2015 and July 2016, saying a potentially defective part could make them fail to activate during a life-threatening allergic reaction.
-
CVS is now selling a rival, generic version of Mylan's EpiPen at about a sixth of its price, just months after the maker of the life-saving allergy...
-
-
-